A comparison study of outcome measures for epidermolysis bullosa: Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and the Instrument for Scoring Clinical Outcomes of Research for Epidermolysis Bullosa (iscorEB)

BACKGROUND: The success of clinical trials in Epidermolysis Bullosa (EB) is dependent upon the availability of a valid and reliable scoring tool that can accurately assess and monitor disease severity. The Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) and Instrument for Scoring...

Descripción completa

Detalles Bibliográficos
Autores principales: Rogers, Clare L., Gibson, Matthew, Kern, Johannes S., Martin, Linda K., Robertson, Susan J., Daniel, Benjamin S., Su, John C., Murrell, Oliver G.C., Feng, Grant, Murrell, Dedee F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362226/
https://www.ncbi.nlm.nih.gov/pubmed/34409361
http://dx.doi.org/10.1016/j.jdin.2020.12.007

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8362226/
https://www.ncbi.nlm.nih.gov/pubmed/34409361
http://dx.doi.org/10.1016/j.jdin.2020.12.007

Ejemplares similares